BIFIDOBACTERIUM LONGUM FOR THE TREATMENT OR PREVENTION OF MAJOR DEPRESSION
Patent Information
- Application Number
- DE602016094709
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2016-08-31
- Publication Date
- 2026-02-11
- Estimated Expiration
- 2036-08-31
AI Technical Summary
Current antidepressant medications often come with significant side effects and require long-term therapy, making them costly and inconvenient for patients, while depressive symptoms not meeting the criteria for major depression are prevalent and poorly addressed.
Administration of Bifidobacterium longum ATCC BAA-999, a probiotic bacteria, which modulates gut-to-brain signaling to improve depressive symptoms and reduce brain emotional activity, offering a natural, side-effect-free alternative for treating and preventing depressive symptoms.
Bifidobacterium longum ATCC BAA-999 effectively improves depressive symptoms and quality of life by down-regulating brain areas involved in emotion control, providing prolonged benefits without the side effects associated with traditional antidepressants and reducing healthcare costs.